InvestorsHub Logo
Followers 19
Posts 334
Boards Moderated 0
Alias Born 07/25/2016

Re: None

Thursday, 11/17/2016 11:48:00 PM

Thursday, November 17, 2016 11:48:00 PM

Post# of 48316
Folks, do you all realize what is going on between ONCS and Ku Leuven's antibody gene transfer program?! The collaboration is literally going to leapfrog conventional systemic checkpoint inhibitors like Keytruda, Opdivo, Yervoy, etc. Pay close attention to today's presentation. Oncosec will provide the new smart electroporation technology as a delivery vehicle for DNA encoded mAbs, in any tissue type including tumors! This is the local delivery of monoclonal antibody DNA that I was talking about recently.

This is an enormous development!!

Mark this post, because you will all one day want to remember this moment of enlightenment.

I had to listen to today's presentation a couple times before I realized what was going on.THIS IS AN INSANELY HUGE DEVELOPMENT.